These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18789393)

  • 61. Development of nitric oxide generators to produce high-dose nitric oxide for inhalation therapy.
    Yu B; Wanderley HV; Gianni S; Carroll RW; Ichinose F; Zapol WM; Berra L
    Nitric Oxide; 2023 Sep; 138-139():17-25. PubMed ID: 37277062
    [TBL] [Abstract][Full Text] [Related]  

  • 62.
    Recchia D; Stelitano G; Stamilla A; Gutierrez DL; Degiacomi G; Chiarelli LR; Pasca MR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902066
    [No Abstract]   [Full Text] [Related]  

  • 63. Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro.
    Rousseaud A; Prot M; Loriere ES; Katz I; Ramirez-Gil JF; Farjot G
    Nitric Oxide; 2023 Mar; 132():27-33. PubMed ID: 36706864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New Developing Treatments for Molluscum Contagiosum.
    Lacarrubba F; Micali G; Trecarichi AC; Quattrocchi E; Monfrecola G; Verzì AE
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2669-2678. PubMed ID: 36239905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High Doses of Inhaled Nitric Oxide as an Innovative Antimicrobial Strategy for Lung Infections.
    Sorbo LD; Michaelsen VS; Ali A; Wang A; Ribeiro RVP; Cypel M
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and practicality of high dose inhaled nitric oxide in emergency department COVID-19 patients.
    Strickland B; Albala L; Coffey EC; Carroll RW; Zapol WM; Ichinose F; Berra L; Harris NS
    Am J Emerg Med; 2022 Aug; 58():5-8. PubMed ID: 35623183
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NO in Viral Infections: Role and Development of Antiviral Therapies.
    Sodano F; Gazzano E; Fruttero R; Lazzarato L
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients.
    Kamenshchikov NO; Berra L; Carroll RW
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications.
    Poh WH; Rice SA
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163933
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel pre-clinical strategy to deliver antimicrobial doses of inhaled nitric oxide.
    Michaelsen VS; Ribeiro RVP; Brambate E; Ali A; Wang A; Pires L; Kawashima M; Zhang Y; Gazzalle A; Keshavjee S; Del Sorbo L; Cypel M
    PLoS One; 2021; 16(10):e0258368. PubMed ID: 34644318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhaled Nitric Oxide Delivery Systems for Mechanically Ventilated and Nonintubated Patients: A Review.
    Gianni S; Carroll RW; Kacmarek RM; Berra L
    Respir Care; 2021 Jun; 66(6):1021-1028. PubMed ID: 34039761
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibacterial activity of high-dose nitric oxide against pulmonary
    Bogdanovski K; Chau T; Robinson CJ; MacDonald SD; Peterson AM; Mashek CM; Wallin WA; Rimkus M; Montgomery F; Lucas da Silva J; Gupta S; Ghaffari A; Zelazny AM; Olivier KN
    Access Microbiol; 2020; 2(9):acmi000154. PubMed ID: 33195983
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting
    Bartley BL; Gardner KJ; Spina S; Hurley BP; Campeau D; Berra L; Yonker LM; Carroll RW
    Case Rep Pediatr; 2020; 2020():1536714. PubMed ID: 32685229
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mode of nitric oxide delivery affects antibacterial action.
    Hall JR; Rouillard KR; Suchyta DJ; Brown MD; Ahonen MJR; Schoenfisc MH
    ACS Biomater Sci Eng; 2020 Jan; 6(1):433-441. PubMed ID: 32671191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitric oxide-releasing alginates as mucolytic agents.
    Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2019 Jul; 5(7):3409-3418. PubMed ID: 32309634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitric Oxide Donor Modulates a Multispecies Oral Bacterial Community-An In Vitro Study.
    Nambu T; Wang D; Mashimo C; Maruyama H; Kashiwagi K; Yoshikawa K; Yamamoto K; Okinaga T
    Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31540050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.
    Stasko N; McHale K; Hollenbach SJ; Martin M; Doxey R
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760128
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications.
    Yang L; Feura ES; Ahonen MJR; Schoenfisch MH
    Adv Healthc Mater; 2018 Jul; 7(13):e1800155. PubMed ID: 29756275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nitric Oxide-Releasing Alginates.
    Ahonen MJR; Suchyta DJ; Zhu H; Schoenfisch MH
    Biomacromolecules; 2018 Apr; 19(4):1189-1197. PubMed ID: 29551064
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Antibiofilm efficacy of nitric oxide on soft contact lenses.
    Kim DJ; Park JH; Kim M; Park CY
    BMC Ophthalmol; 2017 Nov; 17(1):206. PubMed ID: 29162075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.